Mirati: A Potential Blockbuster Stock, Will Need Patience (NASDAQ:MRTX)
Mirati has strong competitive differences against larger rival Amgen. However, lead indication, 2nd line NSCLC, is not where these differences will come out.
Mirati: A Potential Blockbuster Stock, Will Need Patience (NASDAQ:MRTX)
Mirati has strong competitive differences against larger rival Amgen. However, lead indication, 2nd line NSCLC, is not where these differences will come out.